Noravax, a clinical stage biotech focused
on vaccines for infectious diseases, announced the appointment of John Trizzino as SVP, international and
government alliances. Trizzino, previously vice president of MedImmune's
vaccine franchise, will report directly to Noravax president and CEO Rahul
CMI announced three promotions: Lauren Santangelo and Jana Truax were both promoted from assistant
media planner I to media planner I, and Brett
Marvel was promoted from media planner I to media planner II.